Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil McHugh

Showing results (71-80 of 140) with videos related to

Pageof 14
Sort By:
Annals of the Rheumatic Diseases|March 30, 2025
Diagnostic delay and less intensive therapy for people with psoriatic arthritis compared with rheumatoid arthritis: a study nested within an English and Welsh audit data setRachel A Charlton, Emer Gates, Laura C Coates, et al.
Rheumatology (Oxford, England)|March 13, 2024
Assessing the sensitivity and specificity of myositis-specific and associated autoantibodies: a sub-study from the MyoCite cohortAravinthan Loganathan, Latika Gupta, Alex Rudge, et al.
Rheumatology (Oxford, England)|November 8, 2025
A retrospective observational study of effectiveness of sequential biologic and targeted synthetic DMARDs in psoriatic arthritis in the UKCharlotte E Gollins, Annie Russell, Theresa Smith, et al.
British Journal of Clinical Pharmacology|June 5, 2013
A novel assay to measure B cell responses to keyhole limpet haemocyanin vaccination in healthy volunteers and subjects with systemic lupus erythematosusJohn Ferbas, Shelley S Belouski, Michelle Horner, et al.
The Journal of Rheumatology|August 3, 2017
A Multicenter Nominal Group Study to Rank Outcomes Important to Patients, and Their Representation in Existing Composite Outcome Measures for Psoriatic ArthritisWilliam Tillett, Emma Dures, Sarah Hewlett, et al.
The Journal of Rheumatology|November 3, 2014
Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic reviewMaria Laura Acosta Felquer, Laura C Coates, Enrique R Soriano, et al.
Arthritis and Rheumatism|September 2, 2006
Endothelin axis polymorphisms in patients with sclerodermaCarmen Fonseca, Elizabeth Renzoni, Piersante Sestini, et al.
Annals of the Rheumatic Diseases|May 15, 2017
A rare coding allele in <i>IFIH1</i> is protective for psoriatic arthritisAshley Budu-Aggrey, John Bowes, Philip E Stuart, et al.
Clinical Proteomics|July 29, 2023
Proteomic analysis identifies subgroups of patients with active systemic lupus erythematosusKevin Y C Su, John A Reynolds, Rachel Reed, et al.
Rheumatology (Oxford, England)|August 16, 2014
Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre studyWilliam Tillett, Gavin Shaddick, Ayman Askari, et al.
Pageof 14

Showing results (71-80 of 140) with videos related to

Sort By:
Pageof 14
Annals of the Rheumatic Diseases|March 30, 2025
Diagnostic delay and less intensive therapy for people with psoriatic arthritis compared with rheumatoid arthritis: a study nested within an English and Welsh audit data setRachel A Charlton, Emer Gates, Laura C Coates, et al.
Rheumatology (Oxford, England)|March 13, 2024
Assessing the sensitivity and specificity of myositis-specific and associated autoantibodies: a sub-study from the MyoCite cohortAravinthan Loganathan, Latika Gupta, Alex Rudge, et al.
Rheumatology (Oxford, England)|November 8, 2025
A retrospective observational study of effectiveness of sequential biologic and targeted synthetic DMARDs in psoriatic arthritis in the UKCharlotte E Gollins, Annie Russell, Theresa Smith, et al.
British Journal of Clinical Pharmacology|June 5, 2013
A novel assay to measure B cell responses to keyhole limpet haemocyanin vaccination in healthy volunteers and subjects with systemic lupus erythematosusJohn Ferbas, Shelley S Belouski, Michelle Horner, et al.
The Journal of Rheumatology|August 3, 2017
A Multicenter Nominal Group Study to Rank Outcomes Important to Patients, and Their Representation in Existing Composite Outcome Measures for Psoriatic ArthritisWilliam Tillett, Emma Dures, Sarah Hewlett, et al.
The Journal of Rheumatology|November 3, 2014
Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic reviewMaria Laura Acosta Felquer, Laura C Coates, Enrique R Soriano, et al.
Arthritis and Rheumatism|September 2, 2006
Endothelin axis polymorphisms in patients with sclerodermaCarmen Fonseca, Elizabeth Renzoni, Piersante Sestini, et al.
Annals of the Rheumatic Diseases|May 15, 2017
A rare coding allele in <i>IFIH1</i> is protective for psoriatic arthritisAshley Budu-Aggrey, John Bowes, Philip E Stuart, et al.
Clinical Proteomics|July 29, 2023
Proteomic analysis identifies subgroups of patients with active systemic lupus erythematosusKevin Y C Su, John A Reynolds, Rachel Reed, et al.
Rheumatology (Oxford, England)|August 16, 2014
Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre studyWilliam Tillett, Gavin Shaddick, Ayman Askari, et al.
Pageof 14